Skip to main content

Table 3 Differences between non-persistent (NP) and persistent patients

From: Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient’s perspective

 

NP patients

Persistent patients

p

 

N = 99

N = 50

 

(Mean ± SD) years of formal education

11.4 ± 3.8

10 ± 3.9

0.03

(Mean ± SD) months of follow-up

62.7 ± 26.4

50.1 ± 29.5

0.009

N° (%) of patients with ACCP when entering the Clinic

83 (84)

34 (68)

0.04

(Mean ± SD) cumulative DAS28

3.1 ± 1.8

2.2 ± 1.1

0.001

(Mean ± SD) cumulative HAQ

0.4 ± 0.4

0.3 ± 0.3

0.03

N° (%) of patients who selected responses “Slightly, Moderately, Quite a bit or Extremely” to the question (Number 8),

57 (57)

20 (39.5)

0.000

“In the past six months, how much difficulty did you had to find your arthritis medication at the drugstore?”

N° (%) of patients who selected responses “Slightly, Moderately, Quite a bit or Extremely” to the question (Number 9),

92 (93)

42 (80)

0.002

In the past 6 months, how much expensive did you consider was you arthritis medication

   
  1. NP = Non-persistent.
  2. N° = Number.
  3. ACCP = Antibodies to cyclic citrullinated peptides.
  4. DAS28 = Disease activity score (28 joints evaluated).
  5. HAQ = Health assessment questionnaire.